Errik is a member of the Replay Board. He is a bioengineer, entrepreneur, and investor who has founded or co-founded seven venture-backed biotech companies, including Adimab, Alloy Therapeutics, Compass Therapeutics, Alector, Arsanis, and Avitide. He is currently Founder and CEO of Alloy Therapeutics, as well as CEO of his single-family office, Ulysses Diversified Holdings. Errik started his career in venture capital at Lehman Brothers Venture Capital and worked at Bristol-Myers Squibb in marketing. He is Chairman of the Board of Governors at Major League Rugby and an owner of The New England Free Jacks professional rugby team. He received his AB in Economics from Dartmouth, MBA from the Tuck School of Business (where he graduated as a Tuck Scholar), and studied Bioengineering as a graduate student at Thayer School of Engineering.